The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...

SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...

SoftBank’s AI investments face increasing risks, especially in OpenAI and Stargate. Find out why SFTBF stock could be ...

Despite the tariff and DeepSeek turmoil, the U.S. stock market has been going strong in 2025, with the benchmark S&P 500 ...

1) The IPO and sell-down of the core Japanese telecom business. SoftBank sold around 36% of its shares of the core domestic telecom business in 2018 in an IPO, with the proceeds being used for ...

Arm Holdings' stock has surged 157% since its IPO, driven by AI potential, expansion in PC and AI markets, and licensing ...

Alphabet (GOOGL) is joining with OpenAI investor SoftBank (SFTBF) to back quantum computing startup QuEra, as part of a $230 ...

For its third quarter, SoftBank Group booked a net loss of 369.165 billion yen, equivalent to $2.42 billion, compared with a net profit of Y950.00 billion in the year-earlier period. That missed the ...

SoftBank Group reported a quarterly loss, partly due to the weakness in its technology funds business.

Palantir Technologies Inc.’s hefty premium will be in focus when the data analysis software giant reports earnings after the ...

Nvidia (NASDAQ: NVDA) stock was crushed on Jan. 27, dropping 17% in a single session after a fresh wave of doubts came to the ...

Try it Now The Nasdaq-100 in 100 video series provides insights into the Nasdaq-100 Index® and its constituents, all in 100 seconds or less. Sign up for our newsletter to get the latest on the ...